Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction.

Dapagliflozin reduced worsening HF or CV death in HF with reduced ejection fraction. Ann Intern Med. 2020 Feb 18;172(4):JC16 Authors: Sullivan K, Van Spall HGC PMID: 32066149 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32066149?dopt=Abstract

Source: Annals of Internal Medicine - February 17, 2020 Category: Internal Medicine Authors: Sullivan K, Van Spall HGC Tags: Ann Intern Med Source Type: research

More News: Dapagliflozin | Forxiga | Internal Medicine